Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images

Medical Physics

Volumn 34, Issue 4, 2007, Pages 1198-1205

  Chen, Guang Pei ^a   Ahunbay, Ergun ^a   Schultz, Christopher ^a   Li, X Allen ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Biological image guided radiotherapy; Biological treatment planning; Inhomogeneous radiosensitivity; Nonuniform dose distribution

Indexed keywords

MAGNETIC SUSCEPTIBILITY; MATLAB;

BIOLOGICAL TREATMENT; DYNAMIC SUSCEPTIBILITY CONTRAST; EQUIVALENT UNIFORM DOSE; IMAGE GUIDED RADIOTHERAPY; INHOMOGENEOUS RADIOSENSITIVITY; NONUNIFORM DOSE DISTRIBUTION; RADIOSENSITIVITY PARAMETERS; SPATIALLY INHOMOGENEOUS;

RADIOTHERAPY;

ARTICLE; BRAIN BLOOD FLOW; CLINICAL EFFECTIVENESS; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; DOSE CALCULATION; IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOBIOLOGY; RADIOSENSITIVITY; RISK; TISSUE DISTRIBUTION;

EID: 34147140787     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2710948     Document Type: Article

References (33)

1. C. C. Ling and X. A. Li, " Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity., " Med. Phys. 32, 2189-2192 (2005).
2. J. Z. Wang and X. A. Li, " Impact of tumor repopulation on radiotherapy planning., " Int. J. Radiat. Oncol., Biol., Phys. 61, 220-227 (2005).
3. J. O. Deasy, " Partial tumor boosts: Even more attractive than theory predicts? " Int. J. Radiat. Oncol., Biol., Phys. 51, 279-280 (2001).
4. W. A. Tome and J. F. Fowler, " On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours., " Phys. Med. Biol. 48, N261-268 (2003).
5. W. A. Tome and J. F. Fowler, " Selective boosting of tumor subvolumes., " Int. J. Radiat. Oncol., Biol., Phys. 48, 593-599 (2000).
6. J. Oh, R. G. Henry, A. Pirzkall, Y. Lu, X. Li, I. Catalaa, S. Chang, W. P. Dillon, and S. J. Nelson, " Survival analysis in patients with glioblastoma multiforme: Predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume., " J. Magn. Reson Imaging 19, 546-554 (2004).
7. H. J. Aronen, I. E. Gazit, D. N. Louis, B. R. Buchbinder, F. S. Pardo, R. M. Weisskoff, G. R. Harsh, G. R. Cosgrove, E. F. Halpern, and F. H. Hochberg, " Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings., " Radiobiologiia 191, 41-51 (1994).
8. M. Fuss, F. Wenz, M. Essig, M. Muenter, J. Debus, T. S. Herman, and M. Wannenmacher, " Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy., " Int. J. Radiat. Oncol., Biol., Phys. 51, 478-482 (2001).
9. Y. Cao, C. I. Tsien, V. Y. Nagesh, L. Junck, R. Ten Haken, B. D. Ross, T. L. Chenevert, and T. S. Lawrence, " Clinical investigation survival prediction in high grade gliomas by MRI perfusion before and during early stage of RT., " Int. J. Radiat. Oncol., Biol., Phys. 64, 876-885 (2006).
10. M. Alber, F. Paulsen, S. M. Eschmann, and H. J. Machulla, " On biologically conformal boost dose optimization., " Phys. Med. Biol. 48, N31-N35 (2003).
11. Y. Yang and L. Xing, " Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution., " Med. Phys. 32, 1473-1484 (2005).
12. M. A. Ebertyz and P. W. Hoban, " Some characteristics of tumor control probability for heterogeneous tumours., " Phys. Med. Biol. 41, 2125-2133 (1996).
13. A. Niemierko, " Reporting and analyzing dose distributions: A concept of equivalent uniform dose., " Med. Phys. 24, 103-110 (1997).
14. J. F. Fowler, " The linear-quadratic fomula and progress in fractionated radiotherapy., " Br. J. Radiol. 62, 679-694 (1989).
15. X. A. Li, J. Z. Wang, P. A. Jursinic, C. A. Lawton, and D. Wang, " Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer., " Int. J. Radiat. Oncol., Biol., Phys. 61, 1251-1257 (2005).
16. M. A. Ebert, " Viability of the EUD and TCP concepts as reliable dose indicators., " Phys. Med. Biol. 45, 441-457 (2000).
17. T. J. Lyman, " Complication probability-As assessed from dose volume histograms., " Radiat. Res. 104, S13-S19 (1985).
18. X. S. Qi, X. A. Li, K. Kainz, B. Brammer, G. H. Olivera, K. J. Ruchala, C. Schultz, and J. F. Wilson, " Ranking complex IMRT plans using an EUD-based figure-of-merit index., " Int. J. Radiat. Oncol., Biol., Phys. 66, S658 (2006).
19. K. M. Schmainda, S. D. Rand, A. M. Joseph, R. Lund, B. D. Ward, A. P. Pathak, J. L. Ulmer, M. A. Baddrudoja, and H. G. J. Krouwer, " Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis., " AJNR Am. J. Neuroradiol. 25, 1524-1532 (2004).
20. J. L. Boxerman, K. M. Schmainda, and R. M. Weisskoff, " Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not., " AJNR Am. J. Neuroradiol. 27, 859-867 (2006).
21. N. A. Mayr, W. T. C. Yuh, J. C. Arnholt, J. C. Ehrhardt, J. I. Sorosky, V. A. Magnotta, K. S. Berbaum, W. Zhen, A. C. Paulino, L. W. Oberley, A. K. Sood, and J. M. Buatti, " Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer., " J. Magn. Reson Imaging 12, 1027-1033 (2000).
22. Y. Yamashita, T. Baba, Y. Baba, R. Nishimura, S. Ikeda, M. Takahashi, H. Ohtake, and H. Okamura, " Dynamic contrast-enhanced MR imaging of uterine cervical cancer: Pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy., " Radiology 216, 803-809 (2000).
23. J. A. Loncaster, B. M. Carrington, J. R. Sykes, A. P. Jones, S. M. Todd, R. Cooper, D. L. Buckley, S. E. Davidson, J. P. Logue, R. D. Hunter, and C. M. L. West, " Prediction of radiation therapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix., " Int. J. Radiat. Oncol., Biol., Phys. 54, 759-767 (2002).
24. R. Lund, S. Rand, H. Krouwer, C. Schultz, and K. Schmainda, " Using rCBV to distinguish radiation necrosis from tumor recurrence in malignant gliomas., " Int. J. Radiat. Oncol., Biol., Phys. 63, S65-S66 (2005).
25. X. Li, D. B. Vigneron, S. Cha, E. E. Graves, F. Crawford, S. M. Chang, and S. J. Nelson, " Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo., " AJNR Am. J. Neuroradiol. 26, 760-769 (2005).
26. X. S. Qi, C. J. Schultz, and X. A. Li, " An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor., " Int. J. Radiat. Oncol., Biol., Phys. 64, 1570-1580 (2006).
27. C. J. Schultz and C. R. Geard, " Radio response of human astrocytic tumors across grade as a function of acute and chronic irradiation., " Int. J. Radiat. Oncol., Biol., Phys. 10, 1397-1403 (1990).
28. P. E. Gill, W. Murray, and M. H. Wright, Practical Optimization (Academic, London, 1981).
29. S. P. Han, " A globally convergent method for nonlinear programming., " J. Optim. Theory Appl. 22, 297-309 (1977).
30. J. O. Deasy, A. I. Blanco, and V. H. Clark, " CERR: A computational environment for radiotherapy research., " Med. Phys. 30, 979-985 (2003).
31. D. Levin-Plotnik and R. J. Hamilton, " Optimization of tumor control probability for heterogeneous tumors in fractionated radiotherapy treatment protocols., " Phys. Med. Biol. 49, 407-424 (2004).
32. A. Brahme and A. K. Agren, " Optimal dose distribution for eradication of heterogeneous tumors., " Acta Oncol. 26, 377-385 (1987).
33. N. A. Stareva, P. V. Stareva, and W. H. Round, " A mathematical approach to optimizing the radiation dose distribution in heterogeneous tumors., " Acta Oncol. 35, 727-732 (1996).